Very little in the pricing environment in Europe is predictable to pharmaceutical companies and only rarely is much notice given of change. But before the end of 2009, if the European Court of Justice accepts the arguments put to it forcefully by the European Commission and by DocMorris, revolutionary reform among industrys main customer group, the community pharmacist, in several of the main countries, including 4 of the EU-5, will get the green light. The main issue to be resolved, whether national regulations on pharmacy ownership and establishment of new premises infringe EU law, is of wider importance than for the pharmacy profession alone. It amounts to a battle over control of healthcare provision between Brussels and the member states, with the outcome also of great significance to patients, wholesalers, manufacturers and payers. Pharmacy Liberalisation in Europe: Prospects and Implications provides fully-researched, up-to-date information and interpretation on what deregulation could mean to all participants in the medicines market. Whether your interest is in marketing prescription brands, generics or OTCs, in their distribution, or in paying the bill for them, this report is for you. To be forewarned of what might happen will allow adequate preparation for it. The report addresses: Background and current status of infringement actions brought by the European Commission against seven EU member states, plus the key ECJ case involving the controversial DocMorris pharmacy in the German city of Saarbrücken. The arguments for and against reform. What might happen, who would be the winners and the losers. Details of the current ownership structure, and ownership and establishment rules for pharmacies in countries all across Europe from Iceland to Cyprus. Interdependency of pharmacy and wholesaling, and how this could evolve. What lessons can be found from markets that have already deregulated. How vertical integration impacts reimbursement of multisource products and the response by payers to this. The latest on plans to break up Apotekets pharmacy monopoly in Sweden. Table of Contents : Executive Summary 1. Background 1.1 Community Pharmacy 1.2 Pharmacy Regulations 1.3 Intervention by the European Commission 1.4 Limitations on Commission Action For more information please contact :http://www.aarkstore.com/reports/Pharmacy-Liberalisation-in-Europe-Prospects-and-Implications-1050.html http://blogs.aarkstore.com/ From:Aarkstore Enterprise Contact: Neel Email: press@aarkstore.com http://www.aarkstore.com
Tag Archive for Prospects
Pharmacy Liberalisation in Europe: Prospects and Implications- Aarkstore Enterprise
Prospects For Legalizing Drug (Re-)Importation To The United States—-Aarkstore Enterprise
President Barack Obama said during his election campaign he would ‘allow Americans to buy their medicines from other developed countries if the drugs are safe and prices are lower outside the US’. He began delivering on this promise with a fiscal 2010 budget request for funds ‘to allow the FDA to begin developing policies for drug importation’. Earlier in 2009, with strong bipartisan support, Senator Bryon Dorgan (D-ND) re-tabled a bill to allow both personal and commercial drug importation. Obama himself, new White House Chief of Staff Rahm Emanuel and the influential Senator Edward Kennedy were co-sponsors of the identical 2007 version. The new HHS Secretary, Kathleen Sebelius, signed up to a state importation programme when Kansas governor, and has now committed to implementing one at the federal level should the law change. With public and private payers across the country seeking to save every healthcare dollar to get through the economic recession, Dorgan senses a ‘bit of a tailwind’ behind his proposal this time. His supporters are tackling their critics head on with claims that rather than it being dangerous the measure will actually improve drug safety. Through a legislative manoeuvre, and the help of former presidential hopeful Senator John McCain (R-AZ), Dorgan has obtained a commitment from the Senate Majority Leader to bring his bill to the Senate floor for a vote later in 2009. Drug importation is back on the front burner. Is your company prepared? The report addresses: • What is proposed in the Pharmaceutical Market Access and Drug Safety Act of 2009. • Personal and commercial importation in perspective. • Answers to the key questions: Will the bill pass and when? If it passes, will it work and how soon? Where might supplies come from and how? Who would buy and use imported drugs in the US? What are the risks? What would be the savings? • How Canada’s international pharmacy business developed. • Comparison with parallel trade in Europe You’ve heard the sound bites, get the facts and analysis from an acknowledged expert on cross-border trade and international online pharmacy. Whether you want to protect your business in the US, assess the potential for becoming a player in what could be a new channel or a supplier to it, or are concerned about the knock-on effects in the 20 countries initially named as potential sources (inc. Australia, Canada, France, Germany, Italy, Japan, Spain and the UK) this report is essential reading. Table of Contents : Executive Summary 1. Background to Importation 1.1 Healthcare Coverage in US 1.1.1 Employers 1.1.2 Medicare 1.1.3 Medicaid 1.2 US Drug Prices 1.3 Cost Burden 1.4 Why Importation? 1.5. Current Legal Situation with Importation 1.5.1 Importation by Manufacturers 1.5.2 Enforcement Discretion with Personal Importation
2. The Rise, Fall and Partial Recovery of International Pharmacies 2.1 Channel Development in Canada 2.1.1 Standards 2.1.2 Customers 2.1.3 Products 2.1.4 Savings 2.1.5 International Pharmacies in Other Countries 2.1.6 Canadian Backlash 2.2 Canadian-Foreign Pharmacy Partnership 2.3 Preventing Seizures at US Border 2.4 Sales Evolution For more information please contact :http://www.aarkstore.com/reports/Prospects-for-Legalizing-Drug-Re-Importation-to-the-United-States-13937.html http://blogs.aarkstore.com/ From: Aarkstore Enterprise Contact: Neel Email: press@aarkstore.com URL: www.aarkstore.com
Pushpanjali
Marketing Manager
contact@aarkstore.com
http://www.aarkstore.com
http://blogs.aarkstore.com